BioCentury
ARTICLE | Politics & Policy

Regulatory reprieve with Brexit delay

April 11, 2019 8:23 PM UTC

An EU-granted extension for Brexit means short-term clarity for biopharma companies expecting EMA or European Commission decisions before the new Oct. 31 deadline.

The U.K. had been scheduled to leave the union Friday...